Inoculation of plasmid DNA, encoding an immunogenic protein gene of an infectious agent,
stands out as a novel approach for developing new generation vaccines for prevention of …

Summary Infection with Rhodococcus (Corynebacterium) equi is a well‐recognised
condition in foals that represents a consistent and serious risk worldwide. The condition …

Rhodococcus equi is recognised to cause chronic purulent bronchopneumonia in foals of
less than 6 months of age. Virulent strains of the bacteria possess a large 80–90kb plasmid …

For decades researchers have been targeting prevention of R hodococcus equi
(Rhodococcus hoagui/P rescottella equi) by vaccination and the horse breeding industry …

R hodococcus equi infection was first described in horses in 1923.1 It is now recognized
worldwide as a major cause of disease in foals 3 weeks to 6 months of age. The most …

Rhodococcus equi is a Gram-positive facultative intracellular bacterial pathogen and the
most common cause of severe infectious pneumonia in foals. The pathogen is ubiquitous in …

Rhodococcus equi remains a significant bacterial pathogen, causing severe
pyogranulomatous pneumonia in foals aged 1–3 months. There is no effective vaccine …

Rhodococcus equi is a respiratory pathogen which primarily infects foals and is endemic on
farms around the world with 50% mortality and 80% morbidity in affected foals. Unless …

Vaccination is one of the most important and cost-effective methods used for prevention from
the infectious diseases. Inactivated and live-attenuated commercial vaccines are efficient …

The aim of this study was to determine the efficacy of inactive Rhodococcus equi vaccine
candidates included that bacterin+ aluminum hydroxide (Al (OH) 3), bacterin+ VapA+(Al …